so far, the balance sheet is looking healthy.
the special dividend is 15 cents per share.
Underlying EBIT for total business of $129.2 million compared to previous
guidance of $120 ? $130 million
? For the ongoing Healthcare Business:
? Sales Revenue ? $2.9 billion ↑ 6.6% pcp
? Underlying EBIT of $46.7 million (Reported EBIT of ‐$9.1 million)
? Reported NPAT (‐$73.1 million)